Cardiol Therapeutics Inc Class A

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31
Revenue
$0
$0
Gross Profit
-61
-61
EBITDA
-7,679
-8,343
EBIT
-7,741
-8,405
Net Income
-6,590
-9,179
Net Change In Cash
0
0
Free Cash Flow
-4,779
-6,926
Cash
24,021
28,572
Basic Shares
68,751
67,259

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$78
$78
Gross Profit
-248
-219
78
-229
EBITDA
-29,590
-41,156
-38,444
-20,460
EBIT
-29,785
-41,375
-38,664
-20,690
Net Income
-28,128
-30,930
-31,638
-20,640
Net Change In Cash
0
0
78
78
Free Cash Flow
-25
-27,295
-23,563
-9,226
Cash
34,931
59,469
83,899
14,025
Basic Shares
64,463
62,505
43,222
29,857

Earnings Calls

Quarter EPS
2024-09-30
-$0.18
2024-06-30
-$0.10
2024-03-31
-$0.12
2023-12-31
-$0.09